RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 Subset Analyses of ASPECT-cIAI: Ceftolozane/Tazobactam Effective in cIAIs
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 48
SP 16
OP 17
DO 10.1177/1559897715590995
UL http://mdc.sagepub.com/content/15/48/16.abstract
AB The ASPECT-cIAI trial demonstrates high clinical cure rates, similar to those of meropenem, with ceftolozane/tazobactam plus metronidazole in patients with complicated intra-abdominal infections in a European population. In addition, a post hoc analysis shows similar outcomes between patients who are nonobese and obese.